{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:31:53Z","timestamp":1760297513775},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTCNSND"],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.2174\/1568007054546090","type":"journal-article","created":{"date-parts":[[2005,7,27]],"date-time":"2005-07-27T01:29:31Z","timestamp":1122427771000},"page":"325-329","source":"Crossref","is-referenced-by-count":33,"title":["What can Adenosine Neuromodulation do for Neuroprotection?"],"prefix":"10.2174","volume":"4","author":[{"given":"J.","family":"Ribeiro","sequence":"first","affiliation":[]}],"member":"965","container-title":["Current Drug Target -CNS & Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/90292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T05:00:14Z","timestamp":1448254814000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-007X&volume=4&issue=4&spage=325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,1]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568007054546090","relation":{},"ISSN":["1568-007X"],"issn-type":[{"value":"1568-007X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8,1]]}}}